“…Studies that have employed connectivity metrics have had initial successes in identifying AD biomarkers, with some reporting specific functional connectivity changes as the disease progresses. To date, multiple studies have reported RSN disturbances in patients with AD, MCI, presymptomatic autosomal dominant AD mutation carriers, and cognitively normal individuals carrying the APOE ε4 risk allele (Agosta et al, 2012;Badhwar et al, 2017;Dillen et al, 2017;Li et al, 2017;Lopez-Sanz et al, 2017;Nakamura et al, 2017;Schumacher et al, 2018). Our study expands upon these earlier reports by using a twopronged network analysis strategy aiming to more fully characterize FC modular organization, and by testing the robustness of our findings across two independent cohorts of participants.…”